Zacks Research Predicts Stronger Earnings for HealthEquity

HealthEquity, Inc. (NASDAQ:HQY) – Investment analysts at Zacks Research increased their FY2025 earnings per share estimates for HealthEquity in a report released on Monday, December 30th. Zacks Research analyst R. Department now expects that the company will earn $2.30 per share for the year, up from their previous estimate of $2.25. The consensus estimate for HealthEquity’s current full-year earnings is $3.12 per share.

HQY has been the topic of several other research reports. The Goldman Sachs Group assumed coverage on shares of HealthEquity in a report on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price on the stock. Mizuho started coverage on HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price target on the stock. Barrington Research raised their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research report on Monday, December 2nd. BTIG Research increased their target price on shares of HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research note on Thursday, November 14th. Finally, Royal Bank of Canada lifted their price target on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. One research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $110.71.

HealthEquity Stock Performance

NASDAQ:HQY opened at $95.95 on Wednesday. The company has a market capitalization of $8.32 billion, a PE ratio of 88.03, a P/E/G ratio of 1.08 and a beta of 0.55. HealthEquity has a fifty-two week low of $65.01 and a fifty-two week high of $105.82. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 3.20. The company has a 50 day simple moving average of $96.34 and a two-hundred day simple moving average of $85.22.

Insider Buying and Selling

In other news, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the sale, the director now owns 54,719 shares in the company, valued at $4,540,582.62. This trade represents a 13.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Frank Corvino sold 1,039 shares of the company’s stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total value of $99,847.90. Following the completion of the transaction, the director now owns 3,784 shares in the company, valued at approximately $363,642.40. The trade was a 21.54 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 42,539 shares of company stock worth $4,040,303. 2.20% of the stock is owned by corporate insiders.

Institutional Trading of HealthEquity

Hedge funds have recently made changes to their positions in the company. International Assets Investment Management LLC purchased a new position in shares of HealthEquity in the second quarter worth about $35,000. Paladin Wealth LLC purchased a new position in HealthEquity in the 3rd quarter valued at approximately $39,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in HealthEquity during the 2nd quarter valued at $73,000. GAMMA Investing LLC lifted its position in shares of HealthEquity by 57.8% during the third quarter. GAMMA Investing LLC now owns 939 shares of the company’s stock worth $77,000 after acquiring an additional 344 shares in the last quarter. Finally, Quarry LP boosted its holdings in shares of HealthEquity by 418.8% in the third quarter. Quarry LP now owns 1,349 shares of the company’s stock worth $110,000 after acquiring an additional 1,089 shares during the period. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.